180 results
DEFA14A
KURA
Kura Oncology Inc
12 Apr 24
Additional proxy soliciting materials
4:26pm
. Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024
S-8
EX-23.1
KURA
Kura Oncology Inc
27 Feb 24
Registration of securities for employees
4:52pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
S-8
KURA
Kura Oncology Inc
27 Feb 24
Registration of securities for employees
4:52pm
, 2.01, 3.02, 4.01, 5.01, 5.02, 5.03, 5.06 and 9.01).
Opinion of Cooley LLP.
Consent of Independent Registered Public Accounting Firm.
Consent
424B3
lt94r3axj7cjopzui49
15 Feb 24
Prospectus supplement
4:01pm
8-K
EX-4.1
sy8f127x7fxrte2jkh
26 Jan 24
Kura Oncology Announces Oversubscribed
4:08pm
8-K
EX-10.2
sc98 3bdfpl809tpa2r
26 Jan 24
Kura Oncology Announces Oversubscribed
4:08pm
8-K
EX-10.1
cqz 8f1hwoazz
26 Jan 24
Kura Oncology Announces Oversubscribed
4:08pm
8-K
EX-99.1
h6idz4
22 Dec 23
Other Events
9:01am
S-3ASR
EX-4.8
7d6uikqigdrznog
2 Nov 23
Automatic shelf registration
4:39pm
S-3ASR
EX-23.1
cfeta8t mjpg
2 Nov 23
Automatic shelf registration
4:39pm
S-3ASR
r2l4qd11ue
2 Nov 23
Automatic shelf registration
4:39pm